Reproductive Health

ANAHEIM, Calif. — Although race and neighborhood deprivation were closely related, neighborhood deprivation was not associated with IVF outcomes, data presented here suggest.

ANAHEIM, Calif. — Patients who received fertility treatments may be able to have a naturally conceived live birth in the future, data presented here showed.

ANAHEIM, Calif. — In this video exclusive, ASRM President-Elect Michael A. Thomas, MD, discusses his vision for the organization in the coming year.

ANAHEIM, Calif. — Among U.S. residents, Black and Asian women of reproductive age were more likely to have asymptomatic uterine fibroids compared with their white and Hispanic peers, according to data presented here.

ANAHEIM, Calif. — Reducing the embryo warming time from 15 minutes to 1 minute had no significant affect on the pregnancy or implantation rate for patients undergoing frozen embryo transfer, data presented here showed.

ANAHEIM, Calif. — Only half of hospitals across the United States offer health care specifically to transgender and gender-diverse people, and only 23% of those offer fertility care to this population.

ANAHEIM, Calif. — Laparoscopically confirmed endometriosis was associated with increased levels of 15 plasma proteins, data presented here showed.

ANAHEIM, Calif. — Embryos had a lower blastocyst yield when exposed to wildfire smoke during development, according to data presented here.

From Oct. 22 to 26, ASRM will host its Scientific Congress & Expo in a fully in-person format for the first time in 3 years.

The FDA Obstetrics, Reproductive and Urologic Drugs Advisory Committee voted 14-1 to remove a drug indicated for preventing preterm birth from the market due to lack of effectiveness.